Zdrowie i gospodarka · 10/09/2013

FDA Releases Draft Guidance on Bioequivalence Recommendations for Fluticasone Propionate and Salmeterol Xinafoate

The FDA has made available a draft guidance document outlining specific recommendations for designing bioequivalence studies to support abbreviated new drug applications for these two medications, which are used to treat respiratory conditions.